Health Canada drug identification number

DIN 02533618 — SANDOZ RIOCIGUAT 2.5 MG

SANDOZ RIOCIGUAT is a tablet of Riociguat marketed by SANDOZ CANADA INCORPORATED. The full Riociguat monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02533618
Brand name
SANDOZ RIOCIGUAT
Active ingredient
Riociguat
Strength
2.5 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
SANDOZ CANADA INCORPORATED
Health Canada status
MARKETED
Drug class
Soluble guanylate cyclase (sGC) stimulator

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Riociguat products

DINBrandStrengthFormManufacturerStatus
02412764 ADEMPAS 0.5 MG TABLET BAYER INC MARKETED
02412772 ADEMPAS 1 MG TABLET BAYER INC MARKETED
02412799 ADEMPAS 1.5 MG TABLET BAYER INC MARKETED
02412802 ADEMPAS 2 MG TABLET BAYER INC MARKETED
02412810 ADEMPAS 2.5 MG TABLET BAYER INC MARKETED
02533545 SANDOZ RIOCIGUAT 0.5 MG TABLET SANDOZ CANADA INCORPORATED MARKETED
02533561 SANDOZ RIOCIGUAT 1 MG TABLET SANDOZ CANADA INCORPORATED MARKETED
02533588 SANDOZ RIOCIGUAT 1.5 MG TABLET SANDOZ CANADA INCORPORATED MARKETED
02533596 SANDOZ RIOCIGUAT 2 MG TABLET SANDOZ CANADA INCORPORATED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.